Matica Biotechnology is a cell and gene therapy CDMO devoted to production of viral vectors and cell-based products used in cell and gene therapies and other genetic medicines. The company's services include GMP production using suspension platforms, as well as cell and virus banking. Their adeno-associated virus and lentivirus production capabilities aim to help streamline the development and manufacturing cycles to best support their clients in the production of cell and gene therapy vaccines and applications. Matica Bio’s 45,000-sq.-ft. viral vector manufacturing facility in College Station, Texas, offers fully integrated solutions for advanced therapies, vaccines, oncolytic vectors, and other biotherapeutic products.